Skip to main content

Stereotaxis, Inc.

STXS
Exchange
NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001289340

No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Stereotaxis, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of STXS: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders104105+1
Shares41.9M42.7M+833.6K (+2.0%)
Value$130.3M$98.3M−$32.0M (−24.6%)

New holders (13)

Institutions that held Stereotaxis, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to STXS in Q4 2025
InstitutionSharesValue% of portfolio
AlphaCentric Advisors LLC600,000$1.38M1.38%
SEI Investments Co248,441$571.4K0.00%
Z3 Capital Partners, LLC34,000$78.2K0.02%
Thompson Davis & Co., Inc.25,199$57.5K0.03%
Abel Hall, LLC22,957$52.8K0.01%
Equitable Holdings, Inc.20,000$46.0K0.00%
HRT Financial LP18,329$42.0K0.00%
SG Americas Securities, LLC14,463$33.0K0.00%
WealthPLAN Partners, LLC12,665$29.1K0.00%
Daytona Street Capital LLC10,000$23.0K0.02%
GAMMA Investing LLC1,801$4.14K0.00%
MAI Capital Management1,250$2.88K0.00%
Allworth Financial LP14$330.00%

Sold out (12)

Institutions that held Stereotaxis, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of STXS in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Two Sigma Advisers, LP171,600$533.7K
GMT Capital Corp126,581$393.7K
Citadel Advisors LLC102,429$318.6K
Diametric Capital, LP62,875$195.5K
Man Group plc45,692$142.1K
XTX Topco Ltd37,436$116.4K
MetLife Investment Management33,948$105.6K
Virtu Financial LLC22,596$70.0K
Prelude Capital Management, LLC17,394$54.1K
Boothbay Fund Management, LLC17,390$54.1K
Moneta Group Investment Advisors LLC13,862$43.1K
SBI Securities Co., Ltd.28$87